Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Neurology

• Publication date

  2001-10-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.57.8.1497PMID 11673599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic criteria for Parkinson disease.

  1999cited by this paper
• Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.

  1998cited by this paper
• Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)

  1994cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• What features improve the accuracy of clinical diagnosis in Parkinson's disease

  1992cited by this paper
• Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study

  1991cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper

• Vascular parkinsonism: an update

  2025influential citation
• Amygdala-centered fusional connections characterized nonmotor symptoms in Parkinson's disease.

  2025cites this paper
• Validating the Accuracy of Parkinson's Disease Clinical Diagnosis: A UK Brain Bank Case–Control Study

  2025cites this paper
• Retro-Walking and Cholinergic Network Correlates in Parkinson’s Disease

  2025cites this paper
• PARylation in Parkinson’s disease: a bridge between Lewy body formation and neuronal cell death

  2025cites this paper
• Genetics Influences Telomere Length in Parkinson's Disease: A Study in Monozygotic Discordant Twins

  2025cites this paper
• PET tracer development for imaging α-synucleinopathies

  2025cites this paper
• Neurobiochemical alterations in patients with idiopathic Parkinson's disease in sensorimotor cortex using 1H-MRS.

  2025cites this paper
• EMPOWER‐PD: Evaluation of an 8‐Week Co‐Designed Self‐Management Program in People With Parkinson’s Disease and Their Caregivers: An Intervention Study With Long‐Term Follow‐Up

  2025cites this paper
• Peripheral Immune-Inflammatory Parameters in Parkinson’s Disease. Dependence on the Stage of Progression

  2025cites this paper
• Dietary tributyrin supplementation in Parkinson's disease: An open-label target engagement study.

  2025cites this paper
• Development of Positron Emission Tomography Radiotracers for Imaging α-Synuclein Aggregates

  2025cites this paper
• Radiomics analysis of substantia nigra on multi-echo susceptibility map-weighted imaging for differentiating Parkinson’s disease from atypical parkinsonian syndromes

  2025cites this paper
• Evaluation of autonomic involvement in Parkinson’s disease using pupillometry

  2025cites this paper
• Structural-functional connectivity decoupling in multiscale brain networks in Parkinson’s disease

  2024cites this paper
• Plasma acellular transcriptome contains Parkinson’s disease signatures that can inform clinical diagnosis

  2024cites this paper
• A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s disease

  2024cites this paper
• Higher serum Lp-PLA2 is associated with cognitive impairment in Parkinson’s disease patients

  2024cites this paper
• Acupuncture for the Treatment of Neuropsychiatric Symptoms in Parkinson's Disease: A Systematic Review and Meta-Analysis.

  2024cites this paper
• Towards a biological diagnosis of PD.

  2024cites this paper
• Houston, We Have AI Problem! Quality Issues with Neuroimaging‐Based Artificial Intelligence in Parkinson's Disease: A Systematic Review

  2024cites this paper
• A Novel Method of Parkinson’s Disease Detection from Acoustic Features using Machine Learning Systems

  2024cites this paper
• Subthalamic Stimulation Improves Short-Term Satisfaction with Life and Treatment in Parkinson’s Disease

  2024cites this paper
• A Hybrid AI Framework to Address the Issue of Frequent Missing Values with Application in EHR Systems: the Case of Parkinson's Disease

  2024cites this paper
• Deep learning-based detection of affected body parts in Parkinson’s disease and freezing of gait using time-series imaging

  2024cites this paper
• Linking acetylated α-Tubulin redistribution to α-Synuclein pathology in brain of Parkinson’s disease patients

  2024cites this paper
• Convolutional neural network based detection of early stage Parkinson’s disease using the six minute walk test

  2024cites this paper
• The Parkinson's Story of a Neurologist with 32 Years of Experience on Parkinson's Disease.

  2024cites this paper
• Two-Stage Convolutional Neural Network for Classification of Movement Patterns in Tremor Patients

  2024cites this paper
• Efficacy and safety of acupuncture therapy for Parkinson’s disease with neuropsychiatric symptoms: protocol for a systematic review and meta-analysis

  2024cites this paper
• Definition and diagnosis of Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology

  2024cites this paper
• The clinical diagnosis of Parkinson's disease

  2023cites this paper
• Genetic analysis of Mendelian mutations in a large UK population-based Parkinson’s disease study

  2023cites this paper
• Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson's Disease”

  2023cites this paper
• Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest): Development and Pilot Study of a Questionnaire for Stigma in Patients with Idiopathic Parkinson’s Disease

  2023cites this paper
• Clinical Diagnostic Accuracy of Parkinson's Disease: Where Do We Stand?

  2023cites this paper
• Comparing Backward Walking Performance in Parkinson’s Disease with and without Freezing of Gait—A Systematic Review

  2023cites this paper
• Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease

  2023cites this paper
• A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism

  2022cites this paper
• The Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies.

  2022cites this paper
• Astrocytes expressing Vitamin D‐activating enzyme identify Parkinson’s disease

  2022cites this paper
• The faecal metabolome and mycobiome in Parkinson's disease.

  2022cites this paper
• Turning reveals the characteristics of gait freezing better than walking forward and backward in Parkinson's disease.

  2022cites this paper
• The effect of therapeutic exercise on the clinical picture and quality of life of patients with Parkinson's disease: A narrative review and update of evidence-based physioth

  2022cites this paper
• 60 Years of Achievements by KSNM in Neuroimaging Research

  2022cites this paper
• Lewy body disease or diseases with Lewy bodies?

  2022cites this paper
• Reduced cerebral blood flow of lingual gyrus associated with both cognitive impairment and gait disturbance in patients with idiopathic normal pressure hydrocephalus.

  2022cites this paper
• Identification of Altered Blood MicroRNAs and Plasma Proteins in a Rat Model of Parkinson’s Disease

  2022influential citation
• Linking acetylated α-Tubulin redistribution to α-Synuclein pathology in brain of Parkinson’s disease patients

  2022cites this paper
• Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures

  2022cites this paper
• Blunt dopamine transmission due to decreased GDNF in the PFC evokes cognitive impairment in Parkinson’s disease

  2022cites this paper
• A descriptive study of Parkinson disease and atypical parkinsonisms in the Annuals of the Pathological Autopsy Cases in Japan

  2022cites this paper
• Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctions

  2022cites this paper
• Effect of acupuncture for non-motor symptoms in patients with Parkinson’s disease: A systematic review and meta-analysis

  2022cites this paper
• Gut Microbiota in Monozygotic Twins Discordant for Parkinson's Disease

  2022cites this paper
• Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson´s disease: a narrative review

  2022cites this paper
• Attenuated brain white matter functional network interactions in Parkinson's disease

  2022cites this paper
• Confirming Parkinson Disease Diagnosis: Patterns of Diagnostic Changes by Movement Disorder Specialists

  2022cites this paper
• Reference Values for Dopamine Transporter Imaging With 99mTc-TRODAT-1 in Healthy Subjects and Parkinson’s Disease Patients

  2022cites this paper
• Association between Severity of Freezing of Gait and Turning Characteristics in People with Parkinson’s Disease

  2022cites this paper
• Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease

  2022cites this paper
• Acupuncture for Brain: Treatment for Neurological and Psychologic Disorders

  2021cites this paper
• Clinical and Genetic Analysis of Costa Rican Patients With Parkinson's Disease

  2021cites this paper
• Prevalence and incidence of Parkinson’s disease and other forms of parkinsonism in a cohort of elderly individuals in Southern Brazil: protocol for a population-based study

  2021cites this paper
• Presence of Skin α-Synuclein Deposits Discriminates Parkinson’s Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome

  2021cites this paper
• Dopamine transporter (DAT) imaging in Parkinson’s disease and related disorders

  2021cites this paper
• Classification of Parkinson’s disease with freezing of gait based on 360° turning analysis using 36 kinematic features

  2021cites this paper
• Parkinsonism

  2021cites this paper
• Identification of blood-based biomarkers for diagnosis and prognosis of Parkinson's disease: A Systematic review of proteomics studies.

  2021cites this paper
• The New Satisfaction with Life and Treatment Scale (SLTS-7) in Patients with Parkinson’s Disease

  2021cites this paper
• Prionopathies and Prionlike Protein Aberrations in Neurodegenerative Diseases

  2021cites this paper
• Employing in vitro metabolism to guide design of F-labelled PET probes of novel α-synuclein binding bifunctional compounds

  2021cites this paper
• Identification and validation of N-acetylputrescine in combination with non-canonical clinical features as a Parkinson’s disease biomarker panel

  2021cites this paper
• [18F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseases

  2021cites this paper
• Basal ganglia atrophy–associated causal structural network degeneration in Parkinson's disease

  2021cites this paper
• Bone Mineral Density Loss in Parkinson’s Disease: Impact of Clinical Subtypes

  2021cites this paper
• Imaging modalities in differential diagnosis of Parkinson’s disease: opportunities and challenges

  2021cites this paper
• Poly (ADP-ribose) polymerase 1 and Parkinson's disease: a study in post-mortem human brain.

  2021cites this paper
• Sociability‐based fitness approach in Parkinson’s disease: Comparison with conventional rehabilitation

  2021cites this paper
• Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Patients With Parkinson’s Disease

  2021cites this paper
• Early-Onset Parkinson Disease Screening in Patients From Nigeria

  2021cites this paper
• Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein–Containing Extracellular Vesicles

  2021cites this paper
• Diagnostic performance of loss of nigral hyperintensity on susceptibility-weighted imaging in parkinsonism: an updated meta-analysis

  2021cites this paper
• Effects of task-oriented training combined with aerobic training on serum BDNF, GDNF, IGF-1, VEGF, TNF-α, and IL-1β levels in people with Parkinson's disease: A randomized controlled study.

  2021cites this paper
• Diagnostic Evaluation of 99mTc-TRODAT-1 SPECT in Parkinsonism

  2021cites this paper
• Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.

  2021cites this paper
• Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: current status and applications

  2020cites this paper
• Insights Into the Proteomic Profiling of Extracellular Vesicles for the Identification of Early Biomarkers of Neurodegeneration

  2020cites this paper
• Is Levodopa Response a Valid Indicator of Parkinson's Disease?

  2020cites this paper
• Identification of BAG2 and Cathepsin D as Plasma Biomarkers for Parkinson’s Disease

  2020cites this paper
• Neurodegenerative diseases among miners in Ontario, Canada, using a linked cohort

  2020cites this paper
• Clinical correlates of serum 25-hydroxyvitamin D in Parkinson’s disease

  2020cites this paper
• Transcriptomic profiles in Parkinson’s disease

  2020cites this paper
• Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter.

  2020cites this paper
• Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease

  2020cites this paper
• Clinical Diagnostic Accuracy of Early/Advanced Parkinson Disease

  2020cites this paper
• Missing care: A framework to address the issue of frequent missing values;The case of a clinical decision support system for Parkinson's disease

  2020cites this paper
• Enzyme Immunoassay-Based Platform for Accurate Detection of Serum Pathological α-Synuclein in Parkinson's Disease Patients.

  2020cites this paper
• Features in essential tremor and the development of Parkinson’s disease vs. parkinsonism

  2020cites this paper
• Turning Characteristics of the More-Affected Side in Parkinson’s Disease Patients with Freezing of Gait

  2020cites this paper